T 2090/14 (Recombinat human C1 inhibitor/PHARMING) of 22.06.2018
- European Case Law Identifier
- ECLI:EP:BA:2018:T209014.20180622
- Date of decision
- 22 June 2018
- Case number
- T 2090/14
- Online on
- 28 September 2018
- Petition for review of
- -
- Application number
- 04748575.0
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- C1 inhibitor with short half-life for transient treatment
- Applicant name
- Pharming Intellectual Property B.V.
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 123(2)European Patent Convention Art 54(2)European Patent Convention Art 83European Patent Convention Art 84
- Keywords
- Appeal decision - remittal to the department of first instance (yes)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division for further prosecution on the basis of the set of claims of the main request filed during the oral proceedings on 22 June 2018.